Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain

dc.contributor.authorMurray, Colin J.
dc.contributor.authorVecchiarelli, Haley A.
dc.contributor.authorTremblay, Marie-Ève
dc.date.accessioned2024-01-25T22:03:21Z
dc.date.available2024-01-25T22:03:21Z
dc.date.copyright2023en_US
dc.date.issued2023
dc.description.abstractConsumption of cannabis is on the rise as public opinion trends toward acceptance and its consequent legalization. Specifically, the senior population is one of the demographics increasing their use of cannabis the fastest, but research aimed at understanding cannabis’ impact on the aged brain is still scarce. Aging is characterized by many brain changes that slowly alter cognitive ability. One process that is greatly impacted during aging is axonal myelination. The slow degradation and loss of myelin (i.e., demyelination) in the brain with age has been shown to associate with cognitive decline and, furthermore, is a common characteristic of numerous neurological diseases experienced in aging. It is currently not known what causes this age-dependent degradation, but it is likely due to numerous confounding factors (i.e., heightened inflammation, reduced blood flow, cellular senescence) that impact the many cells responsible for maintaining overall homeostasis and myelin integrity. Importantly, animal studies using non-human primates and rodents have also revealed demyelination with age, providing a reliable model for researchers to try and understand the cellular mechanisms at play. In rodents, cannabis was recently shown to modulate the myelination process. Furthermore, studies looking at the direct modulatory impact cannabis has on microglia, astrocytes and oligodendrocyte lineage cells hint at potential mechanisms to prevent some of the more damaging activities performed by these cells that contribute to demyelination in aging. However, research focusing on how cannabis impacts myelination in the aged brain is lacking. Therefore, this review will explore the evidence thus far accumulated to show how cannabis impacts myelination and will extrapolate what this knowledge may mean for the aged brain.en_US
dc.description.reviewstatusRevieweden_US
dc.description.scholarlevelFacultyen_US
dc.description.sponsorshipThis work was supported by research grants from the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) awarded to M-ÈT. HV is the recipient of a CIHR postdoctoral fellowship and is a Michael Smith Health Research BC Research Trainee.en_US
dc.identifier.citationMurray, C. J., Vecchiarelli, H. A., & Tremblay, M-È. (2023). Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain. Frontiers in Aging Neuroscience, 15, 1119552. https://doi.org/10.3389/fnagi.2023.1119552en_US
dc.identifier.urihttps://doi.org/10.3389/fnagi.2023.1119552
dc.identifier.urihttp://hdl.handle.net/1828/15886
dc.language.isoenen_US
dc.publisherFrontiers in Aging Neuroscienceen_US
dc.subjectaged brainen_US
dc.subjectmyelinationen_US
dc.subjectmyelin repairen_US
dc.subjectcannabisen_US
dc.subjectmicrogliaen_US
dc.subjectoligodendrocyteen_US
dc.subjectoligodendrocyte progenitor cellen_US
dc.subjectastrocyteen_US
dc.titleEnhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brainen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
murray_colin_FrontAgingNeurosci_2023.pdf
Size:
3.54 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description: